Tontarra Punches and Rongeurs
Tontarra Medizintechnik GmbH · Decision date Sep 15, 2026
What did the FDA decide?
Tontarra Medizintechnik GmbH received a substantially equivalent (SESE) decision for Tontarra Punches and Rongeurs under 510(k) K260446, dated September 15, 2026, with the application received February 11, 2026. The submission is a traditional 510(k) reviewed by FDA rather than a third party, and it is not a combination product. The classification product code is HAE under regulation 882.4840, with neurology as the regulation medical specialty and review panel. SESE denotes clearance to market, not premarket approval.
The FDA document describes the devices as manually operated, reusable stainless steel instruments indicated for cutting or biting bone during surgery involving the spinal column. They are sterilizable and packaged non-sterile, and the products are categorized as limited contact (24 hours or less) with tissue and bone. The source excerpts do not state the predicate device, the basis for the equivalence determination, or the biological testing results, so those details remain unknown from the available material.
The public record does not include a summary statement or the full decision letter text beyond the excerpts shown, so the scope of any specific testing or labeling commitments cannot be confirmed here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Sep 15, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260446
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Tontarra Medizintechnik GmbH
- Product code
- HAE
- Decision code
- SESE
- Decision date
- Sep 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Rongeur, Manual.
- Applicant
- Tontarra Medizintechnik GmbH
- Product code
- HAE
- FDA device class
- 2
FDA decision timeline
K260446 received
Application receipt date recorded by FDA.
K260446 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Tontarra Medizintechnik GmbH
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Wurmlingen
Sources and methodology
- Original FDA record: K260446
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records